HCA Healthcare, Inc. $HCA Shares Bought by Park Place Capital Corp

Key Points

• Park Place Capital Corp increased its stake in HCA Healthcare by an impressive 2,336.0% in the second quarter, now owning 1,218 shares valued at $474,000.
• HCA Healthcare reported earnings of $6.84 EPS for the last quarter, exceeding analysts' expectations of $6.20, and generated $18.61 billion in revenue.
• The company declared a quarterly dividend of $0.72 per share, with shareholders receiving it on September 30th, reflecting a yield of 0.7%.

Park Place Capital Corp boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2,336.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,218 shares of the company's stock after buying an additional 1,168 shares during the quarter. Park Place Capital Corp's holdings in HCA Healthcare were worth $474,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. Nuveen LLC acquired a new stake in HCA Healthcare during the first quarter valued at $569,217,000. Pacer Advisors Inc. grew its position in HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock valued at $466,815,000 after buying an additional 1,329,618 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. grew its position in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock valued at $615,583,000 after purchasing an additional 587,036 shares during the period. Finally, Abdiel Capital Advisors LP acquired a new stake in shares of HCA Healthcare in the first quarter valued at about $164,835,000. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Stock Up 0.5%

Shares of NYSE:HCA opened at $421.07 on Tuesday. The stock has a market cap of $98.53 billion, a P/E ratio of 17.70, a P/E/G ratio of 1.32 and a beta of 1.41. The firm has a fifty day moving average price of $390.93 and a 200 day moving average price of $370.25. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $422.96.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

Analyst Ratings Changes

HCA has been the topic of several research analyst reports. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Robert W. Baird lifted their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research report on Thursday, August 14th. Cantor Fitzgerald reissued an "overweight" rating and issued a $444.00 price target on shares of HCA Healthcare in a research note on Tuesday, August 26th. Truist Financial raised their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Finally, Barclays raised their price target on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an "overweight" rating in a research note on Thursday, September 18th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $407.75.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.